Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 28-Feb 2022. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4945091018 | Product containing precisely bendamustine hydrochloride 25 milligram/1 vial powder for conventional release solution for infusion (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4945092013 | Bendamustine hydrochloride 25 mg powder for solution for infusion vial | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely bendamustine hydrochloride 25 milligram/1 vial powder for conventional release solution for infusion (clinical drug) | est un(e) (attribut) | Product containing only bendamustine in parenteral dose form (medicinal product form) | true | Inferred relationship | Some | ||
| Product containing precisely bendamustine hydrochloride 25 milligram/1 vial powder for conventional release solution for infusion (clinical drug) | a une forme pharmaceutique (attribut) | Powder for conventional release solution for infusion (dose form) | true | Inferred relationship | Some | ||
| Product containing precisely bendamustine hydrochloride 25 milligram/1 vial powder for conventional release solution for infusion (clinical drug) | Has unit of presentation | Vial (unit of presentation) | true | Inferred relationship | Some | ||
| Product containing precisely bendamustine hydrochloride 25 milligram/1 vial powder for conventional release solution for infusion (clinical drug) | Plays role | Antineoplastic therapeutic role | true | Inferred relationship | Some | ||
| Product containing precisely bendamustine hydrochloride 25 milligram/1 vial powder for conventional release solution for infusion (clinical drug) | Has precise active ingredient | Bendamustine hydrochloride (substance) | true | Inferred relationship | Some | 1 | |
| Product containing precisely bendamustine hydrochloride 25 milligram/1 vial powder for conventional release solution for infusion (clinical drug) | Has basis of strength substance (attribute) | Bendamustine hydrochloride (substance) | true | Inferred relationship | Some | 1 | |
| Product containing precisely bendamustine hydrochloride 25 milligram/1 vial powder for conventional release solution for infusion (clinical drug) | Has presentation strength numerator unit | milligram (qualifier value) | true | Inferred relationship | Some | 1 | |
| Product containing precisely bendamustine hydrochloride 25 milligram/1 vial powder for conventional release solution for infusion (clinical drug) | Has presentation strength denominator unit (attribute) | Vial (unit of presentation) | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Canada English language reference set (foundation metadata concept)
FHIR